Vikki F. Tang
102 Pokfulam Road
Hong Kong, China
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab, lenvatinib, carboplatin and pemetrexed in patients with metastatic non-small cell lung cancer harbouring targetable genomic alterations who progressed on standard tyrosine kinase inhibitors.
Journal: Investigational new drugs
Published: August 25, 2025
Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study.
Journal: Advances in therapy
Published: September 25, 2024
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Journal: Advances in therapy
Published: March 28, 2021
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: December 26, 2020
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: October 22, 2020
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy.
Journal: Postgraduate medical journal
Published: June 25, 2018
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 01, 2014
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
Journal: Gastroenterology
Published: August 21, 2013
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?
Journal: Annals of surgical oncology
Published: March 08, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026